Database : MEDLINE
Search on : myxosarcoma [Words]
References found : 326 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 33 go to page                         

  1 / 326 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 29500126
[Au] Autor:Karlin ET; Yang VK; Prabhakar M; Gregorich SL; Hahn S; Rush JE
[Ad] Address:Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, 200 Westboro Rd, North Grafton, MA 01536, USA.
[Ti] Title:Extracardiac intrapericardial myxosarcoma causing right ventricular outflow tract obstruction in a dog.
[So] Source:J Vet Cardiol;, 2018 Feb 27.
[Is] ISSN:1875-0834
[Cp] Country of publication:Netherlands
[La] Language:eng
[Ab] Abstract:A 13-year-old male castrated pomeranian cross was referred for evaluation of episodes of collapse and a suspected cardiac mass. The presence of a mass at the base of the heart within the pericardial space was confirmed by echocardiography. Additional diagnostics included computed tomography, ultrasound-guided fine-needle aspirate, and thoracic radiographs. The mass was surgically debulked and diagnosed as myxosarcoma via histopathology. This case report describes the diagnostic imaging, laboratory findings, and short-term positive clinical outcome of a dog with a myxosarcoma in a previously undescribed location.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180303
[Lr] Last revision date:180303
[St] Status:Publisher

  2 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29245258
[Au] Autor:Qiu J; Tang L; Han Y; Wang C; Gu T; Li G
[Ad] Address:aDepartment of Radiation OncologybDepartment of PathologycDepartment of Cardiac Surgery, the First Hospital, China Medical University, Shenyang, China.
[Ti] Title:Primary atrial fibromyxosarcoma with multiple-system metastases: A case report.
[So] Source:Medicine (Baltimore);96(49):e8930, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:RATIONALE: Fibromyxosarcoma is common in head and neck, vessel, omentum, and reproductive system, with low-grade malignant behavior. However, primary atrial fibromyxosarcoma with highly malignant behavior is extremely rare. PATIENT CONCERNS: A 34-year-old female presented with oppression in the chest, short breath, and onset of headache as initial symptoms. The preoperative echocardiogram showed a medium-size echogenic mass close to the posterior leaflet of the mitral valve in the left atrium. DIAGNOSIS: Primary atrial fibromyxosarcoma with multiple-system metastases. INTERVENTIONS: The patient underwent surgery, and the tumor was removed completely. The diagnosis of left atrium fibromyxosarcoma was confirmed through postoperative histopathological examination. Positron emission tomography/computed tomography scan was performed, which revealed multiple metastases to left adnexa, bilateral adrenal glands, left iliacus, right lateral ventricle, and skeletal system. OUTCOMES: The patient died of cerebral hernia caused by hemorrhage from the metastatic brain tumor, 30 days after the surgery, without receiving chemotherapy or radiotherapy. LESSONS: Cardiac fibromyxosarcoma is a rare primary malignant cardiac neoplasm, probably with systemic metastases. The possibility of malignancy should be considered as differential diagnosis for cardiac mass.
[Mh] MeSH terms primary: Heart Atria/diagnostic imaging
Heart Atria/pathology
Heart Neoplasms/diagnostic imaging
Heart Neoplasms/pathology
Myxosarcoma/diagnostic imaging
Myxosarcoma/pathology
[Mh] MeSH terms secundary: Adult
Echocardiography
Fatal Outcome
Female
Heart Neoplasms/surgery
Humans
Myxosarcoma/surgery
Neoplasm Metastasis
Positron Emission Tomography Computed Tomography
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1712
[Cu] Class update date: 171225
[Lr] Last revision date:171225
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:171217
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000008930

  3 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29072951
[Au] Autor:Lucas DR
[Ad] Address:From the Department of Pathology, University of Michigan/Michigan Medicine, Ann Arbor, Michigan.
[Ti] Title:Myxoinflammatory Fibroblastic Sarcoma: Review and Update.
[So] Source:Arch Pathol Lab Med;141(11):1503-1507, 2017 Nov.
[Is] ISSN:1543-2165
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Myxoinflammatory fibroblastic sarcoma is a rare soft tissue tumor with most occurring in the distal extremities of adult patients. It has a high rate of local recurrence and a low rate of metastasis. Because it may appear benign on clinical examination, and because the microscopic features are generally underrecognized, it is often inadequately treated and misdiagnosed. In this review, based upon experience and that of the literature, the intent is to highlight salient clinicopathologic features, detail the broad microscopic spectrum including high-grade aggressive variants, review the molecular features, and discuss its relation to hemosiderotic fibrolipomatous tumor.
[Mh] MeSH terms primary: Fibrosarcoma/diagnosis
Myxosarcoma/diagnosis
[Mh] MeSH terms secundary: Diagnosis, Differential
Emperipolesis
Extremities
Fibrosarcoma/immunology
Fibrosarcoma/pathology
Fibrosarcoma/therapy
Hemosiderosis/diagnosis
Hemosiderosis/immunology
Hemosiderosis/pathology
Humans
Lipoma/diagnosis
Lipoma/immunology
Lipoma/pathology
Myxosarcoma/immunology
Myxosarcoma/pathology
Myxosarcoma/therapy
Neoplasm Recurrence, Local
Neoplasms, Fibrous Tissue/diagnosis
Neoplasms, Fibrous Tissue/immunology
Neoplasms, Fibrous Tissue/pathology
Prognosis
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1711
[Cu] Class update date: 171106
[Lr] Last revision date:171106
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:171027
[St] Status:MEDLINE
[do] DOI:10.5858/arpa.2017-0219-RA

  4 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28782436
[Au] Autor:Choi E; Miller AD; Devenish E; Asakawa M; McConkey M; Peters-Kennedy J
[Ad] Address:Section of Anatomic Pathology, Department of Biomedical Sciences (Choi, Miller, Peters-Kennedy).
[Ti] Title:Charcot-Leyden crystals: do they exist in veterinary species? A case report and literature review.
[So] Source:J Vet Diagn Invest;29(6):904-909, 2017 Nov.
[Is] ISSN:1943-4936
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:The Charcot-Leyden crystal (CLC) is a major human eosinophil protein that readily crystallizes; these crystals are common in eosinophilic diseases. Although anecdotal existence of these crystals is known in veterinary pathology, definitive reports do not exist, to our knowledge. We identified eosinophilic crystals in a laryngeal myxosarcoma from a 2-y-old, spayed female, Labrador Retriever dog that were tentatively interpreted as CLCs. However, Ziehl-Neelsen acid-fast stain was negative, arguing against CLCs. The crystals stained red with Masson trichrome, precluding collagen. Periodic acid-Schiff and alcian blue were negative. The crystals stained positively with Okajima, and no myoglobin immunoreactivity was detected, supporting their identity as hemoglobin crystals. In the absence of a hematologic abnormality, these crystals were interpreted to be abnormal hemoglobin breakdown products. Protein sequence comparison was pursued to determine whether a protein similar to CLC exists in mammals. Only 3 nonhuman primate species, the Sumatran orangutan ( Pongo abelii), rhesus macaque ( Macaca mulatta), and cynomolgus monkey ( Macaca fascicularis), had a sequence similarity of >80%. Of the crystal-forming residues, 12 of 54 (22%) were different in the Sumatran orangutan and 15 of 54 (28%) were different in the Macaca spp., which may affect the crystallization process. The lack of reports of CLCs in nonhuman species and our results collectively suggest that CLCs are human-specific.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1708
[Cu] Class update date: 171019
[Lr] Last revision date:171019
[St] Status:In-Process
[do] DOI:10.1177/1040638717725783

  5 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28677418
[Au] Autor:Samuelson JP; Echeverria KO; Foreman JH; Fredrickson RL; Sauberli D; Whiteley HE
[Ad] Address:Departments of Pathobiology (Samuelson, Whiteley), College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL.
[Ti] Title:Metastatic myxosarcoma in a Quarter Horse gelding.
[So] Source:J Vet Diagn Invest;:1040638717719480, 2017 Jul 01.
[Is] ISSN:1943-4936
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:A 22-y-old Quarter Horse gelding was presented to the University of Illinois Veterinary Teaching Hospital for evaluation of increased heart rate and mild colic signs. Rectal examination revealed a large left perirenal mass. Abdominal ultrasonography further confirmed this finding. Thoracic ultrasonography indicated multifocal irregularities on the pleural surface suggestive of consolidation and possibly masses in the lungs. The animal was euthanized. Autopsy findings included a large, firm, expansile, gelatinous retroperitoneal mass that surrounded both kidneys, as well as nodules with similar morphology in the lungs, liver, intestinal mesentery, cecum, and caudal mesenteric artery. Histologically, the masses were composed of neoplastic stellate-to-spindloid cells in abundant mucinous stroma. Neoplastic cells exhibited strong immunoreactivity for vimentin and were negative for pancytokeratin (A1/A3), CD3, CD20, melan A, and synaptophysin. Mucinous stroma was strongly positive with alcian blue and weakly positive with periodic acid-Schiff histochemical staining. These findings are consistent with metastatic myxosarcoma. Myxosarcoma is a rare neoplasm in horses, and metastasis to tissues other than sentinel lymph nodes has not been described previously to our knowledge.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1707
[Cu] Class update date: 170705
[Lr] Last revision date:170705
[St] Status:Publisher
[do] DOI:10.1177/1040638717719480

  6 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28264709
[Au] Autor:Jevremovic V; Yousuf A; Hussain Z; Abboud A; Chedrawy EG
[Ad] Address:Department of Surgery, Weiss Memorial Hospital, Chicago, IL, USA.
[Ti] Title:A rare presentation of myxofibrosarcoma as a Pancoast tumor: a case report.
[So] Source:J Med Case Rep;11(1):61, 2017 Mar 07.
[Is] ISSN:1752-1947
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: Myxofibrosarcoma is an aggressive soft tissue neoplasm, classified as a variant of malignant fibrous histiocytoma. Most often, it occurs in middle to late adult life peaking in the seventh decade and involving the lower extremities (77%), trunk (12%), and retroperitoneum or mediastinum (8%). We report the first case of thoracic myxofibrosarcoma presenting as a Pancoast tumor. CASE PRESENTATION: A 48-year-old non-tobacco smoking African-American man presented with a slow-growing mass in his neck along with 11 kg weight loss over 9 months. A review of his systems was positive for hoarseness and lowgrade intermittent fever without any shortness of breath or cough. A physical examination revealed a mass on the left side of his neck superior to his sternoclavicular joint measuring 3 × 3 × 1 cm. He had ptosis and miosis of his left eye. His breath sounds were decreased and coarse at the left apex. A neurological examination revealed 3/5 strength in his left upper arm. The remainder of the physical examination was unremarkable. Ultrasound of his neck showed an ill-defined heterogeneous mass lateral to his left thyroid lobe. A computed tomography scan of his chest showed a large multiloculated pleural-based mass in his left lung surrounding the adjacent neurovascular structures. A percutaneous biopsy was non-diagnostic. Subsequently, he underwent a left thoracotomy with biopsy. The mass extended from his anterior mediastinum medially at the level of the pulmonary trunk, superiorly into the superior sulcus and posteriorly into his chest wall. Surgical pathology confirmed the diagnosis of myxofibrosarcoma. CONCLUSIONS: Here we present a case of Pancoast tumor with myxofibrosarcoma as the underlying etiology. Pancoast syndrome generally entails an infiltrating lesion in the superior sulcus presenting with upper extremity pain, atrophy of the hand muscles, and Horner's syndrome. The differential diagnosis of Pancoast syndrome includes inflammatory and infectious etiologies, as well as neoplasms of benign and malignant nature. Of the neoplasms implicated, the most common are non-small cell lung carcinomas; myxofibrosarcoma presenting as a Pancoast tumor has not been reported in the literature.
[Mh] MeSH terms primary: Antineoplastic Agents, Alkylating/therapeutic use
Fibrosarcoma/diagnosis
Head and Neck Neoplasms/diagnosis
Ifosfamide/therapeutic use
Myxosarcoma/diagnosis
Pancoast Syndrome/pathology
Soft Tissue Neoplasms/diagnosis
Tomography, X-Ray Computed
[Mh] MeSH terms secundary: Biopsy, Large-Core Needle/methods
Blepharoptosis/etiology
Fibrosarcoma/pathology
Fibrosarcoma/therapy
Head and Neck Neoplasms/complications
Head and Neck Neoplasms/therapy
Humans
Male
Middle Aged
Miosis/etiology
Myxosarcoma/pathology
Myxosarcoma/therapy
Pancoast Syndrome/etiology
Pancoast Syndrome/therapy
Soft Tissue Neoplasms/complications
Soft Tissue Neoplasms/therapy
Treatment Outcome
Weight Loss
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Nm] Name of substance:0 (Antineoplastic Agents, Alkylating); UM20QQM95Y (Ifosfamide)
[Em] Entry month:1706
[Cu] Class update date: 170622
[Lr] Last revision date:170622
[Js] Journal subset:IM
[Da] Date of entry for processing:170308
[St] Status:MEDLINE
[do] DOI:10.1186/s13256-017-1223-5

  7 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 27909132
[Au] Autor:Ghazala CG; Agni NR; Ragbir M; Dildey P; Lee D; Rankin KS; Beckingsale TB; Gerrand CH
[Ad] Address:Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle Upon Tyne NE7 7DN, UK.
[Ti] Title:Myxofibrosarcoma of the extremity and trunk: a multidisciplinary approach leads to good local rates of LOCAL control.
[So] Source:Bone Joint J;98-B(12):1682-1688, 2016 Dec.
[Is] ISSN:2049-4408
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:AIMS: Myxofibrosarcomas (MFSs) are malignant soft-tissue sarcomas characteristically presenting as painless slowly growing masses in the extremities. Locally infiltrative growth means that the risk of local recurrence is high. We reviewed our experience to make recommendations about resection strategies and the role of the multidisciplinary team in the management of these tumours. PATIENTS AND METHODS: Patients with a primary or recurrent MFS who were treated surgically in our unit between 1997 and 2012 were included in the study. Clinical records and imaging were reviewed. A total of 50 patients with a median age of 68.4 years (interquartile range 61.6 to 81.8) were included. There were 35 men; 49 underwent surgery in our unit. RESULTS: The lower limb was the most common site (32/50, 64%). The mean size of the tumours was 8.95 cm (1.5 to 27.0); 26 (52%) were French Fédération Nationale des Centres de Lutte Contre le Cancer grade III. A total of 21 (43%) had positive margins after the initial excision; 11 underwent further excision. Histology showed microscopic spread of up to 29 mm beyond macroscopic tumour. Local recurrence occurred in seven patients (14%) at a mean of 21 months (3 to 33) and 15 (30%) developed metastases at a mean of 17 months (3 to 30) post-operatively. CONCLUSION: High rates of positive margins and the need for further excision makes this tumour particularly suited to management by multidisciplinary surgical teams. Microscopic tumour can be present up to 29 mm from the macroscopic tumour in fascially-based tumours. Cite this article: Bone Joint J 2016;98-B:1682-8.
[Mh] MeSH terms primary: Fibrosarcoma/surgery
Myxosarcoma/surgery
Soft Tissue Neoplasms/surgery
[Mh] MeSH terms secundary: Aged
Aged, 80 and over
Disease Management
Female
Fibrosarcoma/secondary
Humans
Lower Extremity
Male
Medical Audit/methods
Middle Aged
Myxosarcoma/secondary
Neoplasm Grading
Neoplasm Recurrence, Local
Patient Care Team
Prognosis
Retrospective Studies
Survival Analysis
Upper Extremity
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1702
[Cu] Class update date: 170214
[Lr] Last revision date:170214
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:161203
[St] Status:MEDLINE

  8 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 27875090
[Au] Autor:Parslow A; Taylor DP; Simpson DJ
[Ti] Title:Clinical, computed tomographic, magnetic resonance imaging, and histologic findings associated with myxomatous neoplasia of the temporomandibular joint in two dogs.
[So] Source:J Am Vet Med Assoc;249(11):1301-1307, 2016 Dec 01.
[Is] ISSN:1943-569X
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:CASE DESCRIPTION A 15-year-old neutered female mixed-breed dog (dog 1) and an 11-year-old neutered female Labrador Retriever (dog 2) were examined because of unilateral exophthalmus, third eyelid protrusion, and periorbital swelling that failed to respond to antimicrobial treatment. CLINICAL FINDINGS Both dogs underwent ultrasonographic, CT, and MRI examination of the head. In both dogs, advanced imaging revealed a poorly defined, peripherally contrast-enhancing, mucous-filled cystic mass that radiated from the temporomandibular joint and infiltrated the periorbital tissues and retrobulbar space. Both dogs underwent surgical biopsy of the periorbital mass. A viscous, straw-colored fluid was aspirated from the retrobulbar region in both dogs. The initial histologic diagnosis for dog 1 was zygomatic sialadenitis and sialocele. However, the clinical signs recurred, and histologic examination of specimens obtained during a second surgical biopsy resulted in a diagnosis of myxoma. The histologic diagnosis was myxosarcoma for dog 2. TREATMENT AND OUTCOME In both dogs, clinical signs recurred within 2 weeks after surgery and persisted for the duration of their lives. Dog 1 received no further treatment after the second surgery and was euthanized 34 months after initial examination because of multicentric lymphoma. Dog 2 was treated with various chemotherapy agents and was euthanized 11 months after initial examination because of a dramatic increase in periocular swelling and respiratory stertor. CLINICAL RELEVANCE Temporomandibular myxomatous neoplasia can be confused with zygomatic sialocele on the basis of clinical signs but has characteristic MRI features. Representative biopsy specimens should be obtained from areas close to the temporomandibular joint to avoid misdiagnosis.
[Mh] MeSH terms primary: Dog Diseases/diagnostic imaging
Myxoma/veterinary
Temporomandibular Joint Disorders/veterinary
[Mh] MeSH terms secundary: Animals
Antineoplastic Agents/therapeutic use
Dog Diseases/pathology
Dog Diseases/therapy
Dogs
Female
Myxoma/diagnostic imaging
Myxoma/pathology
Myxoma/therapy
Temporomandibular Joint Disorders/diagnostic imaging
Temporomandibular Joint Disorders/pathology
Temporomandibular Joint Disorders/therapy
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Nm] Name of substance:0 (Antineoplastic Agents)
[Em] Entry month:1707
[Cu] Class update date: 170817
[Lr] Last revision date:170817
[Js] Journal subset:IM
[Da] Date of entry for processing:161123
[St] Status:MEDLINE

  9 / 326 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 27180128
[Au] Autor:Naghavi AO; Gonzalez RJ; Scott JG; Mullinax JE; Abuodeh YA; Kim Y; Binitie O; Ahmed KA; Bui MM; Saini AS; Zager JS; Biagioli MC; Letson D; Harrison LB; Fernandez DC
[Ad] Address:Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
[Ti] Title:Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.
[So] Source:Brachytherapy;15(4):495-503, 2016 Jul-Aug.
[Is] ISSN:1873-1449
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:PURPOSE: Prior studies illustrated a reduction in wound complications with the use of staged reconstruction (SR) and negative pressure wound therapy when treating soft tissue sarcoma (STS) with surgical resection followed by high-dose-rate adjuvant brachytherapy. The purpose of this study is to compare the outcomes of SR and immediate reconstruction (IR) brachytherapy in recurrent STS. METHODS AND MATERIALS: A retrospective review of 40 patients with recurrent STS of the local extremity and trunk treated with resection followed by adjuvant brachytherapy alone. Margin status was defined as positive (SM(+)) if there was microscopic involvement (R1) or ≤1 mm margin and negative (SM(-)) if >1 mm margin was obtained. SR and IR were compared regarding toxicity, local control, and limb preservation. RESULTS: Median followup was 27 months. When comparing the SR (n = 22) and IR (n = 18) cohorts, there was a significantly lower final SM(+) rate in SR (32% vs. 83%, p < 0.01). A 2-year local control benefit seen with SR (80% vs. 34%; p = 0.012) and a final SM(-) (81% vs. 39%; p = 0.023). SR was associated with less toxicity on multivariate analysis, including a 90% decrease in persistent edema, an 80% decrease in wound dehiscence, and a 94% decrease in nonhealing wounds, when compared to IR. Ten of 31 (32%) extremity cases required eventual amputation from either chronic wound complications (n = 4) or local recurrence (n = 6). SR predicted for a benefit in 2-year limb preservation (88% vs. 50%; p = 0.008). CONCLUSION: In our series, the treatment with SR brachytherapy resulted in less morbidity and an improved final SM(-) rate. This technique translated to an improvement in both local control and limb preservation of recurrent STS.
[Mh] MeSH terms primary: Brachytherapy/methods
Negative-Pressure Wound Therapy/methods
Neoplasm Recurrence, Local/radiotherapy
Reconstructive Surgical Procedures
Sarcoma/radiotherapy
Soft Tissue Neoplasms/radiotherapy
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
Extremities
Female
Fibrosarcoma/radiotherapy
Follow-Up Studies
Humans
Liposarcoma/radiotherapy
Male
Margins of Excision
Middle Aged
Multivariate Analysis
Myxosarcoma/radiotherapy
Radiotherapy Dosage
Radiotherapy, Adjuvant/methods
Retrospective Studies
Surgical Flaps
Time Factors
Wound Healing
Young Adult
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1707
[Cu] Class update date: 170726
[Lr] Last revision date:170726
[Js] Journal subset:IM
[Da] Date of entry for processing:160516
[St] Status:MEDLINE

  10 / 326 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 27093459
[Au] Autor:Weeden AL; Struthers JD; Craft SL; Souza CH; Stacy NI
[Ad] Address:Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA.
[Ti] Title:What is your diagnosis? Perineal mass in a dog.
[So] Source:Vet Clin Pathol;45(2):385-6, 2016 Jun.
[Is] ISSN:1939-165X
[Cp] Country of publication:United States
[La] Language:eng
[Mh] MeSH terms primary: Dog Diseases/diagnosis
Myxosarcoma/veterinary
[Mh] MeSH terms secundary: Animals
Dogs
Male
Myxosarcoma/diagnosis
Perineum/pathology
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1704
[Cu] Class update date: 170404
[Lr] Last revision date:170404
[Js] Journal subset:IM
[Da] Date of entry for processing:160420
[St] Status:MEDLINE
[do] DOI:10.1111/vcp.12341


page 1 of 33 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information